IMGN Financial Facts
Loss from operations: -38.84MResearch and development: 32.91M
See Full Income Statement
Commitments and contingencies (Note E): 0
Accumulated deficit: -898.42M
See Full Balance Sheet
Immunogen Inc. (IMGN) Earnings
|
Expand Research on IMGN
Next EPS Date | 4/25/24 *Est. | EPS Growth Rate | N/A |
---|---|---|---|
Average EPS % Beat Rate | +73.5% | Revenue Growth Rate | N/A |
Average % Move 1-Wk after EPS | +51.9% | Normal Earnings Time | Before Open |
Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
---|---|---|---|---|---|---|---|---|---|---|---|
8/4/16 | Q416 | -$0.51 | -$0.39 | -$0.12 | $7.41M | $17.11M | N/A | Details | |||
2/17/17 | Q217 | -$0.39 | -$0.38 | -$0.01 | $13.85M | $18.1M | = | Details | |||
10/28/16 | Q117 | -$0.51 | -$0.38 | -$0.13 | $7.66M | $21.12M | = | Details | |||
1/29/16 | Q216 | -$0.38 | -$0.36 | -$0.02 | N/A | $17.87M | N/A | Details | |||
10/27/15 | Q116 | -$0.39 | -$0.35 | -$0.04 | $14.9M | $15.84M | N/A | Details | |||
7/31/15 | Q415 | -$0.71 | -$0.35 | -$0.36 | $12.61M | $15.42M | N/A | Details | |||
5/5/17 | Q117 | -$0.20 | -$0.34 | +$0.14 | $28.5M | $16.16M | = | Details | |||
8/2/19 | Q219 | -$0.29 | -$0.33 | +$0.04 | $15.54M | $9.48M | = | Details |